Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome
about
Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleatorsMolecular regulation of tendon cell fate during developmentEffect of serum and insulin modulation on the organization and morphology of matrix synthesized by bovine corneal stromal cells.Col V siRNA engineered tenocytes for tendon tissue engineeringTargeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype.Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model.Loss of fibulin-4 disrupts collagen synthesis and maturation: implications for pathology resulting from EFEMP2 mutationsDiverse biological functions of extracellular collagen processing enzymesMinor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfationPericellular proteins of the developing mouse tendon: a proteomic analysis.Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skinVesicoureteral reflux and the extracellular matrix connection.Collagen V localizes to pericellular sites during tendon collagen fibrillogenesisTendon protein synthesis rate in classic Ehlers-Danlos patients can be stimulated with insulin-like growth factor-I.Lentiviral-encoded shRNA silencing of proteoglycan decorin enhances tendon repair and regeneration within a rat model.Collagen V expression is crucial in regional development of the supraspinatus tendon.Transient expression of mouse pro-α3(V) collagen gene (Col5a3) in wound healing.
P2860
Q24645430-8BAA5B8A-51A7-4E46-9EF2-53E76096C90FQ26829280-6F706DDB-3F65-4688-99F1-5A2A7AA5D2FCQ30492290-B91D24E5-7257-4AC7-8EE9-F4B484E5D39FQ33945381-0B771FCC-74DA-4DC9-8E2F-37A3304EC026Q35568095-E3C593D5-68FE-4FC1-B182-A640B99F7969Q35630667-FDAB5A80-CC8B-4E33-B395-2EE99F9AA812Q36089400-CB53A074-1753-4B62-BE40-14FFC86B95A1Q36259191-8958412A-9D30-44DC-A9BB-15A98FAED2A5Q36359165-90C123F5-E20B-417B-9365-BEF8C3EAF470Q37165625-EC1F1B4A-30B4-4A88-929F-62197AEF9678Q37280652-0295E283-6B87-4731-9B94-A7D6E785DF51Q37733382-806413D0-34FD-4526-AEC1-E76960F3CEA0Q41957565-A8F8C2C0-EB14-436E-9996-C530D4470A53Q42202703-357C90C8-CC4B-4C85-9C9D-0DE0FBEB3B14Q45884155-611340D6-3FAC-4C65-B875-684A2CF845FCQ46639026-1DE5DF56-2E88-4417-B382-E878F3AB7765Q54331176-DCC53E66-6FB7-46F9-982B-0CF5245A6F17
P2860
Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@ast
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en-gb
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@nl
type
label
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@ast
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en-gb
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@nl
prefLabel
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@ast
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en-gb
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@nl
P2093
P921
P356
P1476
Reduced type I collagen utiliz ...... ficient Ehlers-Danlos syndrome
@en
P2093
David E Birk
Jane B Florer
Marcia C Willing
Richard J Wenstrup
William G Cole
P304
P356
10.1002/JCB.20024
P407
P577
2004-05-01T00:00:00Z